Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Other Accumulated Expenses: 2011-2016

  • RedHill Biopharma's Other Accumulated Expenses rose 8.27% to $772,000 in Q4 2016 from the same period last year, while for Dec 2016 it was $772,000, marking a year-over-year increase of 8.27%. This contributed to the annual value of $772,000 for FY2016, which is 8.27% up from last year.
  • Latest data reveals that RedHill Biopharma reported Other Accumulated Expenses of $772,000 as of Q4 2016, which was up 8.27% from $713,000 recorded in Q4 2015.
  • Over the past 5 years, RedHill Biopharma's Other Accumulated Expenses peaked at $772,000 during Q4 2016, and registered a low of $300,000 during Q4 2012.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $713,000 (2015), whereas its average is $634,000.
  • Data for RedHill Biopharma's Other Accumulated Expenses shows a peak YoY spiked of 70.98% (in 2015) over the last 5 years.
  • Quarterly analysis of 5 years shows RedHill Biopharma's Other Accumulated Expenses stood at $300,000 in 2012, then increased by 21.00% to $363,000 in 2013, then increased by 14.88% to $417,000 in 2014, then skyrocketed by 70.98% to $713,000 in 2015, then grew by 8.27% to $772,000 in 2016.
  • Its last three reported values are $772,000 in Q4 2016, $713,000 for Q4 2015, and $417,000 during Q4 2014.